Fiduciary Trust Co Trims Stock Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Fiduciary Trust Co cut its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 2.7% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 15,600 shares of the medical instruments supplier’s stock after selling 436 shares during the quarter. Fiduciary Trust Co owned approximately 0.07% of Mettler-Toledo International worth $23,395,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Family Firm Inc. acquired a new stake in shares of Mettler-Toledo International during the second quarter worth approximately $25,000. Blue Trust Inc. raised its stake in shares of Mettler-Toledo International by 242.9% in the 3rd quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 17 shares in the last quarter. Ashton Thomas Securities LLC bought a new position in shares of Mettler-Toledo International during the third quarter worth about $37,000. Rothschild Investment LLC acquired a new position in Mettler-Toledo International in the second quarter worth about $42,000. Finally, Itau Unibanco Holding S.A. bought a new stake in Mettler-Toledo International in the second quarter valued at about $42,000. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Elisha W. Finney sold 76 shares of the firm’s stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the completion of the sale, the director now directly owns 240 shares in the company, valued at approximately $314,820. This trade represents a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 1.94% of the company’s stock.

Analyst Ratings Changes

MTD has been the topic of a number of research analyst reports. Wells Fargo & Company reduced their target price on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a report on Monday, November 11th. Robert W. Baird decreased their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday, November 11th. Evercore ISI boosted their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Stifel Nicolaus cut their target price on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research report on Monday, August 5th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, Mettler-Toledo International currently has an average rating of “Hold” and an average price target of $1,338.75.

Mettler-Toledo International Price Performance

MTD opened at $1,243.75 on Thursday. The business has a 50 day moving average price of $1,352.26 and a two-hundred day moving average price of $1,396.49. The company has a market capitalization of $26.24 billion, a price-to-earnings ratio of 33.53, a price-to-earnings-growth ratio of 4.04 and a beta of 1.16. Mettler-Toledo International Inc. has a 1-year low of $1,059.08 and a 1-year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating the consensus estimate of $10.00 by $0.21. The business had revenue of $954.54 million during the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. Equities analysts expect that Mettler-Toledo International Inc. will post 40.39 EPS for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.